Compare IZEA & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IZEA | INCR |
|---|---|---|
| Founded | 2006 | 1994 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Advertising | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.5M | 50.4M |
| IPO Year | 2010 | 2021 |
| Metric | IZEA | INCR |
|---|---|---|
| Price | $3.47 | $0.76 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 68.9K | 23.9K |
| Earning Date | 03-17-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 100.00 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $20,099,695.00 | N/A |
| Revenue This Year | $20.81 | $69.54 |
| Revenue Next Year | N/A | $41.75 |
| P/E Ratio | $54.43 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.68 | $0.68 |
| 52 Week High | $5.86 | $1.77 |
| Indicator | IZEA | INCR |
|---|---|---|
| Relative Strength Index (RSI) | 45.54 | 35.55 |
| Support Level | $3.44 | $0.72 |
| Resistance Level | $4.05 | $0.88 |
| Average True Range (ATR) | 0.26 | 0.03 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 21.41 | 22.63 |
IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.